{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:50:15Z","timestamp":1767135015584,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd009683","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T00:00:00Z","timestamp":1492128000000}}],"reference-count":64,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009683.pub2","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T08:40:29Z","timestamp":1492159229000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Topiramate for essential tremor"],"prefix":"10.1002","volume":"2017","author":[{"given":"Elisa","family":"Bruno","sequence":"first","affiliation":[{"name":"University of Catania; Department GF Ingrassia, Section of Neurosciences; Catania Italy 95123"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Nicoletti","sequence":"additional","affiliation":[{"name":"University of Catania; Department GF Ingrassia, Section of Neurosciences; Catania Italy 95123"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziella","family":"Quattrocchi","sequence":"additional","affiliation":[{"name":"University of Catania; Department GF Ingrassia, Section of Neurosciences; Catania Italy 95123"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Allegra","sequence":"additional","affiliation":[{"name":"Policlinico Universitario G. Martino Messina; Department of Neurological Sciences; Via Consolare Valeria Messina Italy 90100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziella","family":"Filippini","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS, Istituto Neurologico Carlo Besta; Scientific Direction; via Celoria, 11 Milan Italy 20133"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Colosimo","sequence":"additional","affiliation":[{"name":"Terni University Hospital; Department of Neurology; Terni Italy 05100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Zappia","sequence":"additional","affiliation":[{"name":"University of Catania; Department GF Ingrassia, Section of Neurosciences; Catania Italy 95123"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,4,14]]},"reference":[{"key":"10.1002\/14651858.CD009683.pub2-BIB0001|cit1","first-page":"1","article-title":"Prospective double blind study of the use of topiramate vs. placebo in the treatment of essential tremor","volume":"44","author":"Carrasco Vargas","year":"2011","journal-title":"Neurologia, Neurocirugia, Psiquiatria"},{"issue":"2","key":"10.1002\/14651858.CD009683.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/WNF.0b013e3180d09969","article-title":"Topiramate\u00a0in\u00a0essential tremor: findings from double-blind, placebo-controlled, crossover trials","volume":"31","author":"Connor","year":"2008","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/01.wnl.0000200779.03748.0f","article-title":"Topiramate in essential tremor: a double-blind, placebo-controlled trial","volume":"66","author":"Ondo","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD009683.pub2-BIB0004|cit4","first-page":"188","article-title":"Topiramate\u00a0in refractory\u00a0essential tremor","volume":"45","author":"Bermejo","year":"2007","journal-title":"Revista Neurologia"},{"issue":"2","key":"10.1002\/14651858.CD009683.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00002826-200603000-00007","article-title":"A double-blind, placebo-controlled, crossover trial of\u00a0topiramate\u00a0in\u00a0essential tremor","volume":"29","author":"Frima","year":"2006","journal-title":"Clinical Neuropharmacology"},{"issue":"6","key":"10.1002\/14651858.CD009683.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/1531-8249(200006)47:6<837::AID-ANA24>3.0.CO;2-2","article-title":"Topiramate\u00a0and\u00a0essential tremor","volume":"47","author":"G\u00e1lvez-Jim\u00e9nez","year":"2000","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD009683.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00002826-200311000-00006","article-title":"Low doses of\u00a0topiramate\u00a0are effective in\u00a0essential tremor: a report of three cases","volume":"26","author":"Gatto","year":"2003","journal-title":"Clinical Neuropharmacology"},{"issue":"2","key":"10.1002\/14651858.CD009683.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.parkreldis.2006.05.032","article-title":"Combined\u00a0topiramate\u00a0and declorazepam therapy in a patient affected by\u00a0essential tremor","volume":"13","author":"Siniscalchi","year":"2007","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"10.1002\/14651858.CD009683.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/wnf.0b013e31811edc69","article-title":"Low-dose\u00a0topiramate\u00a0(Topamax) in the treatment of\u00a0essential tremor","volume":"30","author":"Zesiewicz","year":"2007","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0010|cit10","first-page":"305","article-title":"The effectiveness of treatments for essential tremor","volume":"3","author":"Bain","year":"1997","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0011|cit11","first-page":"77","article-title":"Clinical measurement of tremor","volume":"13 Suppl 3","author":"Bain","year":"1998","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0012|cit12","first-page":"7","article-title":"Criteria for the diagnosis of essential tremor","volume":"54 Suppl 4","author":"Bain","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0013|cit13","first-page":"26","article-title":"Tremor assessment and quality of life measurements","volume":"54 Suppl 4","author":"Bain","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2004.07.010","article-title":"Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (Eilat VII)","volume":"61","author":"Bialer","year":"2004","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.41.12.1982","article-title":"Is essential tremor benign?","volume":"41","author":"Busenbark","year":"1991","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD009683.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/mds.870120621","article-title":"Agreement among movement disorder specialists on the clinical diagnosis of essential tremor","volume":"12","author":"Chouinard","year":"1997","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1002\/14651858.CD009683.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.59.1.132","article-title":"A double-blind placebo-controlled trial of\u00a0topiramate\u00a0treatment for\u00a0essential tremor","volume":"59","author":"Connor","year":"2002","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0018|cit18","first-page":"2","article-title":"Consensus statement of the Movement Disorder Society on tremor. Ad Hoc Scientific Committee","volume":"13 Suppl 3","author":"Deuschl","year":"1998","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0019|cit19","first-page":"1","article-title":"Essential tremor","volume":"54 Suppl 4","author":"Deuschl","year":"2000","journal-title":"Neurology"},{"issue":"13","key":"10.1002\/14651858.CD009683.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/mds.25648","article-title":"Task Force Report: scales for screening and evaluating tremor. Critique and recommendations","volume":"28","author":"Elble","year":"2013","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0021|cit21","first-page":"225","article-title":"Clinical rating scale for tremor","volume-title":"Parkinson' s Disease and Movement Disorders","author":"Fahn","year":"1993"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0022|cit22","first-page":"1","article-title":"Definitions and behavioural classifications","volume-title":"Handbook of Tremor Disorders","author":"Findley","year":"1995"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0023|cit23","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A The Grading of Recommendations Assessment, Development and Evaluation (GRADE) profile (pro) and Guideline development tool (GDT) 2014"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/archneur.1982.00510240012003","article-title":"Prevalence of essential tremor: results from the Copiah county study","volume":"39","author":"Haerer","year":"1992","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0025|cit25","volume-title":"Managing Clinically Important Drug Interactions","author":"Hansten","year":"2004"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0027|cit27","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1212\/WNL.38.2.241","article-title":"Efficacy of alprazolam for essential tremor","volume":"38","author":"Huber","year":"1988","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0029|cit29","first-page":"P04.068","article-title":"Topiramate in essential tremor: pooled data from a double-blind, placebo-controlled, crossover trial","volume":"Abstracts","author":"Hulihan","year":"2003","journal-title":"American Academy of Neurology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mds.870110306","article-title":"A randomized, double-blind, placebo controlled study to evaluate botulinum toxin type A in essential tremor","volume":"11","author":"Jankovic","year":"1996","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mds.10221","article-title":"Essential tremor: a heterogeneous disorder","volume":"17","author":"Jankovic","year":"2002","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1212\/WNL.36.7.1001","article-title":"Disability in essential tremor: effect of treatment","volume":"36","author":"Koller","year":"1986","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.39.12.1587","article-title":"Acute and chronic effects of propranolol and primidone in essential tremor","volume":"39","author":"Koller","year":"1989","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1172\/JCI200523625","article-title":"Genetic essential tremor in gamma-aminobutyric acid A receptor alpha1 subunit knockout mice","volume":"115","author":"Kralic","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/archneur.55.6.823","article-title":"Diagnostic criteria for essential tremor","volume":"55","author":"Louis","year":"1998","journal-title":"Archives of Neurology"},{"issue":"12","key":"10.1002\/14651858.CD009683.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1056\/NEJMcp010928","article-title":"Clinical practice, essential tremor","volume":"342","author":"Louis","year":"2001","journal-title":"New England Medical Journal"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/1531-8257(200101)16:1<89::AID-MDS1001>3.0.CO;2-L","article-title":"A teaching videotape for the assessment of essential tremor","volume":"16","author":"Louis","year":"2001","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1474-4422(05)00991-9","article-title":"Essential tremor","volume":"4","author":"Louis","year":"2005","journal-title":"Lancet Neurology"},{"issue":"5","key":"10.1002\/14651858.CD009683.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/mds.22838","article-title":"How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor","volume":"25","author":"Louis","year":"2010","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parkreldis.2004.09.004","article-title":"Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol","volume":"11","author":"Morita","year":"2005","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1531-8257(200007)15:4<678::AID-MDS1012>3.0.CO;2-0","article-title":"Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial","volume":"15(4)","author":"Ondo","year":"2000","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0042|cit42","first-page":"LBS.004","article-title":"Topiramate for essential tremor","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mds.870130315","article-title":"Double-blind placebo-controlled study of gabapentin in essential tremor","volume":"13","author":"Pahwa","year":"1998","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0002-9343(03)00259-6","article-title":"Essential tremor: differential diagnosis for the development of novel therapeutics","volume":"115","author":"Pahwa","year":"2003","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/jnnp.47.5.466","article-title":"Essential tremor in Rochester, Minnesota: a 45-year study","volume":"47","author":"Rajput","year":"1984","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0046|cit46","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1212\/WNL.44.1.61","article-title":"Prevalence of essential tremor: a door to-door survey in Terrasini, Sicily","volume":"44","author":"Salemi","year":"1994","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics and mechanism of action","volume":"41 Suppl 1","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0049|cit49","doi-asserted-by":"crossref","DOI":"10.1002\/9780470753286","volume-title":"Handbook of Epilepsy Treatment","author":"Shorvon","year":"2005"},{"issue":"7146","key":"10.1002\/14651858.CD009683.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1136\/bmj.316.7146.1719","article-title":"Understanding controlled trials: crossover trials","volume":"316","author":"Sibbald","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0051|cit51","first-page":"418","article-title":"A community survey of Parkinson's disease","volume":"141","author":"Snow","year":"1989","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/mds.21412","article-title":"Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor","volume":"22","author":"Stacy","year":"2007","journal-title":"Movement disorders"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0053|cit53","volume-title":"Essential Tremor Epidemiology, Diagnosis and Treatment","author":"Sullivan","year":"2004"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00002826-198403000-00004","article-title":"A double-blind trial of clonazepam in benign essential tremor","volume":"7","author":"Thompson","year":"1984","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(03)00183-9","article-title":"Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures","volume":"116","author":"Ueda","year":"2003","journal-title":"Molecular Brain Research"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0056|cit56","first-page":"90","article-title":"Pharmacologic treatment of tremor","volume":"13 Suppl 3","author":"Wasielewski","year":"1998","journal-title":"Movement Disorders"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0057|cit57","first-page":"5","article-title":"Mechanism of action of newer anticonvulsants","volume":"62 Suppl 8","author":"White","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1526-4610.2005.4501006.x","article-title":"Molecular pharmacology of topiramate: managing seizures and preventing migraine","volume":"45","author":"White","year":"2005","journal-title":"Headache"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.eplepsyres.2005.10.001","article-title":"Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptors","volume":"67","author":"Yoshida","year":"2005","journal-title":"Epilepsy Research"},{"issue":"3","key":"10.1002\/14651858.CD009683.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00415-012-6628-x","article-title":"Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association","volume":"260","author":"Zappia","year":"2013","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s11910-002-0008-3","article-title":"Management of essential tremor","volume":"2","author":"Zesiewicz","year":"2002","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"12","key":"10.1002\/14651858.CD009683.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000163769.28552.CD","article-title":"Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"64","author":"Zesiewicz","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009683.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mds.21282","article-title":"A double-blind placebo-controlled trial of zonisamide (Zonegran) in the treatment of essential tremor","volume":"22","author":"Zesiewicz","year":"2007","journal-title":"Movement Disorders"},{"issue":"19","key":"10.1002\/14651858.CD009683.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e318236f0fd","article-title":"Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"77","author":"Zesiewicz","year":"2011","journal-title":"Neurology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009683.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T23:02:26Z","timestamp":1704236546000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009683.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Movement Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,14]]},"references-count":64,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009683.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,14]]}}}